Received Feb 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | — | — |
No Side effects/No Additional AE; adult patient received a pediatric dose of RECOMBIVAX HB; This spontaneous report was received from a nurse and refers to a 60-year-old male patient. His medical history, concurrent conditions and concomitant therapies were not provided. On 12-FEB-2025, the patient was vaccinated with pediatric dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) 2.5/0.5 (unit not provided), 0.5 mL, administered for prophylaxis (anatomical location, route of administration, lot # and expiration date were not reported) (Vaccine underdose). No side effects/ no additional adverse events. Lot # is being requested and will be submitted if received.